key: cord-0795419-70qhho65
authors: Chiara, Matteo; Horner, David S.; Ferrandi, Erika; Gissi, Carmela; Pesole, Graziano
title: Unsupervised classification of SARS-CoV-2 genomic sequences uncovers hidden genetic diversity and suggests an efficient strategy for genomic surveillance
date: 2021-06-23
journal: bioRxiv
DOI: 10.1101/2021.06.23.449558
sha: a9111368e4d9aa4972f710fb48e135ba727414db
doc_id: 795419
cord_uid: 70qhho65

Accurate and timely monitoring of emerging genomic diversity is crucial for limiting the spread of potentially more transmissible/pathogenic strains of SARS-CoV-2. At the time of writing, over 1.8M distinct viral genome sequences have been made publicly available, and a sophisticated nomenclature system based on phylogenetic evidence and expert manual curation has allowed the relatively rapid classification of emerging lineages of potential concern. Here, we propose a complementary approach that integrates fine-grained spatiotemporal estimates of allele frequency with unsupervised clustering of viral haplotypes, and demonstrate that multiple highly frequent genetic variants, arising within large and/or rapidly expanding SARS-CoV-2 lineages, have highly biased geographic distributions and are not adequately captured by current SARS-CoV-2 nomenclature standards. Our results advocate a partial revision of current methods used to track SARS-CoV-2 genomic diversity and highlight the importance of the application of strategies based on the systematic analysis and integration of regional data. Here we provide a complementary, completely automated and reproducible framework for the mapping of genetic diversity in time and across different geographic regions, and for the prioritization of virus variants of potential concern. We believe that the approach outlined in this study will contribute to relevant advances to current genomic surveillance methods.

The timely and accurate identification of emerging variants of a pathogen is one of the most important and ambitious goals of genomic surveillance strategies and represents the first line of defense for limiting the spread of more severe/contagious forms of an infectious disease 1 lineages are currently under scrutiny by international health authorities due to their widespread and sustained circulation, coupled with the presence, in the spike glycoprotein, of recurrent mutations associated with increased infectivity and/or reduced neutralization by antibodies 5, 6 . Collectively these lineages are known under the acronym VOC (Variant of Concern) or VOI (Variant of Interest) and represent a substantial source of concern for the success of national vaccination campaigns and the effectiveness of measures for the containment of COVID-19 7 . SARS-CoV-2 VOCs and VOIs show a highly biased geographic distribution (Table 1) , and until recently 8 were typically designated by the country of first isolation. While most lineages are compact in size (median 91.5 distinct genomes), the 10 most numerous lineages in the Pango nomenclature incorporate more than 67% of the available genomes. For example, the B.1.1.7 VOC lineage (also known as 20I/501Y.V1 or Variant of Concern 202012/01 (VOC-202012/01)), accounts for over 795 thousand genomes, and is currently the most widely sampled in Europe and worldwide. It was first detected in southern UK in mid-December 2020, and by the beginning of January 2021 had become the most prevalent lineage in that country 9 , with similar dynamics subsequently observed in other European countries 10 . Similar to other VOCs, specific mutations in the B.1.1.7 lineage have been linked with an increased ability to escape from neutralising antibodies and a higher affinity for the human viral receptor hACE2 11 . Data from the UK and Ireland suggest that B.1.1.7 exhibits increased transmissibility 9 , and preliminary observations also suggest a greater disease severity and higher mortality rates 12 .

Although the widespread circulation of B.1.1.7, at least in Western countries, reflects the evolutionary success of this lineage and the efficacy of contemporary approaches to SARS-CoV-2 genomic surveillance in tracking VOCs, several lines of evidence suggest that current sampling of SARS-CoV-2 genomic sequences might be substantially biased 13 due to various factors including: local incidence of COVID-19 14 , access to state of the art molecular diagnostic test and sequencing facilities 15, 16 , bioinformatics bottlenecks in the analyses of the data and sharing of the results 17, 18 , as well as the application of different rationales and criteria by local health authorities in the implementation of genomic surveillance strategies.

These biases pose relevant questions about the accuracy and completeness of current estimates of the prevalence of SARS-CoV-2 lineages, with possible implications for genomic surveillance of the pathogen.

We and others 19, 20 have recently proposed strategies based on the phenetic clustering of prevalent alleles (with Allele Frequency, AF, > 1%) for the delineation of current and emerging viral genetic diversity in SARS-CoV-2. Here we extend our approach to integrate regional estimates of allele frequency and to facilitate a more rapid and accurate delineation of local variants of SARS-CoV-2. By applying our revised approach to the complete collection of more than 1.8M complete genome sequences of SARS-CoV-2 we demonstrate that our method can identify all current VOCs and VOIs in an unsupervised manner, with reduced turn-around times and high accuracy. Additionally, and particularly in the large and rapidly spreading B.1.1.7 lineage, we outline the presence of several genetic variants with highly biased geographical distributions, which are not captured by current nomenclature standards and which represent a hidden layer of genomic diversity. Finally, by applying simple unsupervised learning methods, based on state of the art clustering algorithms and dimensionality reduction techniques, we present a simple, yet accurate computational strategy for the rapid and automatic identification of VOC and VOI-like SARS-CoV-2 lineages, and provide interesting observations concerning the recurrent mutations associated with these viral variants.

Taken together, we believe that the main results and the approach outlined in this work can provide a substantial contribution to current and future methods for genomic surveillance strategies of human pathogens. A collection of tools and software for the automated analysis of SARS-CoV-2 genomic sequence data is made publicly available at https://github.com/matteo14c/assign_CL_SARS-CoV-2.

Biased sampling and geographic diversity in SARS-CoV-2 genomic data Currently, submissions of publicly available SARS-CoV-2 genomic sequences from the USA and the UK account for more than 65% of currently available genomic sequences. As outlined in Supplementary Figure S1A , the total number of deposited genomic sequences is extremely variable across different geographic regions. Moreover, for many countries, sequence production does not correlate with the incidence of COVID-19 (Supplementary Table S1 ). Figure S3A , B, C). Interestingly, a more clear separation is observed between European and non-European macro-areas (and countries) starting from approximately day 350 ( Figure 1C and Suppl. Figure S3C) We reasoned that systematic differences in the number of genomic sequences available from distinct geographic areas, together with the observed discrepancies in their overall quality and completeness, could represent relevant issues for the correct classification and mapping of SARS-CoV-2 genomic diversity. To investigate this hypothesis we decided to modify our recently developed 19 system for the classification of SARS-CoV-2 genomic sequences by:

1. relaxing the criteria for the definition of "high quality" genomic sequences (originally defined as sequences longer than 29,850 nt and including less than 150 ambiguous sites), in order to obtain a more uniform sampling;

2. incorporating regional estimates of allele frequencies;

3. refining the criteria for the definition of high frequency alleles (originally defined as those achieving an allele frequency greater than 1% for more than 50 days in total).

Modifications of these three classification criteria were as below.

1) Given the potential for affecting estimates of allele frequencies, and the observation that the large majority (87%) of "low quality" sequences were incomplete either at 5' and/or 3' UTR, criteria for inclusion of sequences in our analyses were partially relaxed (see Materials and Methods). As a consequence, a more uniform proportion of "high quality" genomes was observed across different countries (see Supplementary Table S4 ).

2) Allele frequencies were estimated separately for different geographic areas (as defined in Suppl 3) Different values for the definition of high frequency alleles were tested, using both different allele frequency thresholds (0.5 to 5%) and different thresholds for their persistence in the viral population (10 to 100 non-consecutive days). The different combinations were evaluated both with respect to the total number of haplogroups (HG) formed, and considering their ability to reconstruct groups corresponding to the current 4 VOCs and 12

VOIs in a timely and accurate manner. The results of these tests are summarized in Table 2 .

A minimum allele frequency of 1% and a persistence threshold of 15 or more days were selected as the most appropriate combination of parameters for the definition of highfrequency alleles in our classification system. When applied to the complete collection of Similarly, HG284 -a small HG consisting of c.a. 900 genomic sequences which is specifically associated with Sweden -79.4% of the genomes forming this HG being deposited from that country (Supplementary Table S8 ) -includes the S494P substitution in the recognition binding motif of the spike glycoprotein. This substitution is predicted to be under positive selection according to Hyphy, has been recently shown to increase the affinity for the host target receptor hACE2 25 , and has been postulated to facilitate the escape from the recognition by some antibodies 26 . Currently, B.1.1.7+S494P is recognized as a "distinct"

(from B.1.1.7) VOI by international health authorities, and has been subjected to more dedicated monitoring.

Unsurprisingly, the ORF8 gene, which is thought to have been inactivated by a stop-gain in an ancestor of the B.1.1.7 lineage 27 , is associated with an excess of deleterious substitutions in HGs corresponding with the B.1.1.7. These include: a further stop-gain mutation at residue K68, which is collectively associated with 45 HGs and more than 340K genomic sequences; a single nucleotide deletion (at residue I121) which is associated with more than 27K sequence and 6 HGs; and a single base insertion (at residue 119D) which is observed in 4 HGs and affects more than 22K genomes (Supplementary Table S6 ). Both of these indels would cause the elongation of an intact ORF8 by a few amino acids (I121SK and DFI119EFHLN respectively in Supplementary Table S6) .

Additionally, we observe that 14 HGs, with a total of more than 64K genomic sequences and c.a. 9% of the viral isolates currently associated with B.1.1.7, carry a premature truncation of the Orf7a protein (184C>T,p.Q62*). Interestingly, several independent studies have reported SARS-CoV-2 isolates with unique in-and out-of-frame deletions in Orf7a resulting in heavily truncated and/or non functional polypeptides 28, 29 . Although the implications of these mutations are not completely understood at present, we observe that more recently, depletion of Orf7a has been linked with reduced inactivation of the host immune system by SARS-CoV-2 30 Figure 3A and 3B, show a good level of separation between the clusters. Strikingly, in both Figure 3A and 3B we observe that the large majority of VOCs/VOIs grouped in a single cluster: in the analysis of the Pango lineages, 15 over 16 VOCs/VOIs grouped in cluster 2 (see C2lin in Figure 3A ); in the analysis of HGs, with the only exception of HG114 (i.e., the HG in B.1.1.7 that might be associated with systematic sequencing/assembly errors and was assigned to cluster 1 (see C1HG in Figure 3B ), all the HGs corresponding to the 16 VOCs/VOIs were contained in cluster 3 (see C3HG in Figure 3B ). These results clearly indicate that the simple metrics adopted in this work can reliably identify compact and discrete groups of SARS-CoV-2

variants that incorporate all current VOCs/VOIs regardless of the classification system (Pango or HGs). This suggests that they could both be effectively applied to facilitate the identification of potential VOCs and VOIs emerging in the future. Although the equivalence between the HGs of our system and Pango is not complete, cumulatively high levels of agreement were observed between C2lin and C3HG, with more than 67% of the Pango lineages/HGs being common between the two clusters (P-val hypergeometric ⩽ 1 e-16).

Compared to the remaining clusters, clusters associated with VOCs and VOIs displayed an overall increase in genomic diversity, a higher number of substitutions (both synonymous and nonsynonymous), and an increased proportion of incompletely fixed alleles, irrespectively of the allele frequency threshold (see Supplementary Figure S5A VOIs in the S glycoprotein, including E484K, N50Y and L452R, along with several additional mutations, whose significance has been already confirmed by in vitro studies (see for example L18F, G142D, S494P and others mutations in Supplementary Table S15 ).

Genomic surveillance of SARS-CoV-2 requires rapid and effective approaches for the identification of novel strains/lineages as they emerge, coupled with accurate models for the prioritization of variants of potential concern and the identification of strains that should be subjected to more careful/strict observations and characterization. Ideally these approaches should be completely automated, to reduce turn-around times and to avoid potential biases in the classification of viral strains/lineages.

Here, we use a simple and transparent analysis of the available SARS-CoV-2 genomic sequences, to demonstrate systematic and recurrent biases in the current sampling of SARS-CoV-2 genomic diversity, and the consequent implications for the rapid characterization of current and future VOCs and VOIs. Additionally, we highlight possible limitations of Pango, the current standard for the classification and nomenclature of SARS-CoV-2, which may prevent the rapid and unsupervised identification of emergent "regional" genomic diversity.

By applying a revised implementation of the strategy proposed in Chiara et al 19 , based on relaxed filters for the inclusion of low-quality genomic assemblies and on the incorporation of regional estimates of allele frequencies, we present a novel, completely automated system for the monitoring of this genomic diversity. Importantly, we observe that our revised approach can correctly associate one or more related haplogroups to all current Variants of (Table 3) . Our approach requires, on average, 20 days between the availability of the first genomic sequence associated with a VOC/VOI and the formation of a corresponding HG. This timeframe is completely in line with that observed for the reporting of current VOCs and VOIs, although no manual intervention is required by our framework. of relevant new haplotypes. Importantly, we observe that similar considerations apply also to many other rapidly-expanding SARS-CoV-2 lineages (see Table 4 ), and most important to several VOCs/VOIs (6 over 16). The case of the B.1.617.2 Pango lineage, which is rapidly becoming the most prevalent lineage of SARS-CoV-2 in the UK and which is currently associated with 8 distinct HGs in our system, is emblematic in this respect.

Finally, we show that simple unsupervised clustering approaches of SARS-CoV-2 lineages/haplogroups with similar patterns of mutations can be applied for the identification of SARS-CoV-2 variants of potential epidemiological relevance. Our approach recapitulates several important findings regarding the main mutations in the spike glycoprotein that characterize VOI and VOC lineages, and provides a reliable and automatic method for the prioritization of SARS-CoV-2 variants which might potentially represent a source of concern.

Due to its profound mechanistic importance, and thanks to our detailed appreciation of its molecular interactions, SARS-CoV-2 nomenclature standards have tended to focus on variants in the S gene, whose potential biological significance can often be rapidly flagged In conclusion we believe that the current work provides several distinct lines of evidence to demonstrate the accuracy and efficacy of fully automated "epidemiogenomic" approaches, such as the one described here, in drawing attention to emerging variants of SARS-CoV-2 as epidemiological significant in a timely manner and accurate manner. Based on these considerations we suggest that a more accurate and comprehensive system for the mapping and tracking of SARS-CoV-2 genomic diversity should flank the Pango system. 

The complete collection of SARS-CoV-2 genomic sequences and associated metadata (including lineage designation according to the Pango nomenclature) was retrieved directly from gisaid.org on June 3rd 2021. Data concerning the incidence and total number of cases of COVID-19 were downloaded from the WHO dashboard, at https://covid19.who.int/ on the same day.

Custom Perl scripts were used to infer the size of each genomic assembly and the number of uncalled bases/gaps (denoted by N in the genomic sequence). High quality genomic assemblies were initially defined, according to the criteria outlined in Chiara et al 19 , as genome sequences longer than 29,850 nt and including less than 150 ambiguous sites.

Since systematic differences were here observed when comparing genomic assemblies derived from different countries (Table S10) , and due to the frequent incompleteness of the 5'-and/or 3'-UTR (having a length of 229 and 265 nt, respectively), these criteria were revised in order to prevent possible biases in the computation of allele frequency distributions. Therefore, sequences with less than 150 ambiguous sites, and with less than 350 bases missing at either the 3' or 5' end of the genome (i.e longer than 29,550 nt) were now considered of high quality. Only sequences satisfying these criteria were considered for the computation of allele frequency and for the definition of SARS-CoV-2 haplogroups.

Bioinformatics analyses for the delineation of novel HGs and the assignment of genomic sequences to HGs were performed according to the methods described in Chiara et al 20 .

Briefly, SARS-CoV-2 genomes were aligned to the 29,903 nt-long reference assembly of SARS-CoV-2 by means of the nucmer program 38 . Genetic variants were identified by means of the show-snp utility. Allelic frequencies were computed using a custom Perl script.

Genomic sequences were assigned to a geographic region and/or a macro-area based on the country of origin of the genome, as reported in the GISAID database. Correspondence between countries and geographic areas is reported in Supplementary An haplogroup was considered to be associated with a specific country when 50% or more of the genomic sequences included in the haplogroup were associated with that country, and/or when the same condition applied to the first 50 isolated genomic sequences of the haplogroup.

SARS-CoV-2 phylogeny in newick format was obtained from the Audacity 41 tool in GISAID 2 .

The "node purity" of SARS-CoV-2 HGs in the tree was established using a custom script based on the ape R package 42 . Briefly, for every HG all the distinct nodes in the tree containing at least 50 genomic sequences of that HG were retrieved, and the proportion of HG members with respect to the total number of sequences descending from the node was calculated. The node purity was computed as the weighted (by the number of genomes) average of the proportions observed at every node. Alignments of SARS-CoV-2 proteincoding genes were performed by the means of the Muscle 43 software. Identification of sites under selection was performed by applying the MEME and FEL methods, as implemented in the Hyphy package 23 , to the phylogeny and the concatenated alignment of protein-coding sequences. A P-value of 0.05 was considered for the significance threshold. Only sites predicted to be under positive selection according to both methods were considered. For sites predicted to be under negative selection, only FEL was used, since MEME can not identify purifying selection 44 .

All statistical analyses and tests were performed by means of the stats 45 Table S1 for the correspondence between geographic areas and countries. report the total number of HGs formed in distinct continents. The optimal combination of parameters is indicated in red and bold. Table S1 for the correspondence between geographic areas and countries. Figure S5A ) and HGs (in Figure S5B ). Boxplots display global distribution of each distinct feature described in Supplementary Table S12 Figure 1 legend for the acronyms. The last 3 columns indicate the total number of reported cases, the incidence of COVID-19 (number of cases per 100.000 population) and the total number of Pango lineages detected in each country. Table S10 : Total number of genomes and proportion of high quality (HQ) genomes associated with each haplogroup. HGs with % HQ genomes < 65% are reported in bold. The last column indicates the "node purity" in the phylogenetic tree (see methods). 

Genomics and epidemiological surveillance

Global initiative on sharing all influenza data -from vision to reality

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

European Centre for Disease Prevention and Control-1. Sequencing of SARS-CoV-2: first update

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. The Lancet Microbe

Warchal S et al Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

New SARS-CoV-2 Variants -Clinical, Public Health, and Vaccine Implications

SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature

European Centre for Disease Prevention and Control-2. SARS-CoV-2 -increased circulation of variants of concern and vaccine rollout in the EU/EEA, 14th update -15

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Geographic and Genomic Distribution of SARS-CoV-2 Mutations

Testing at scale during the COVID-19 pandemic

Combating Covid-19 pandemic in Africa: An urgent call to scale up laboratory testing capacities

One year after the arrival of COVID-19 in Latin America: what have we learned in Brazil and other countries?

Sharing COVID data? Check these recommendations and guidelines

Comparative genomics reveals early emergence and biased spatio-temporal distribution of SARS-CoV-2

Analysis of genomic distributions of SARS-CoV-2 reveals a dominant strain type with strong allelic associations

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021

HyPhy 2.5-A Customizable Platform for Evolutionary Hypothesis Testing Using Phylogenies

Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations

Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates

An 81-Nucleotide Deletion in SARS-CoV-2

ORF7a Identified from Sentinel Surveillance in Arizona

SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression

Fast unfolding of communities in large networks

UMAP: Uniform Manifold Approximation and Projection

A mobile genetic element with unknown function found in distantly related viruses

Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China

Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission

The type I interferon response in COVID-19: implications for treatment

Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2

MUMmer4: A fast and versatile genome alignment system

CorGAT: a tool for the functional annotation of SARS-CoV-2 genomes

European Centre for Disease Prevention and Control. SARS-CoV-2 variants of concern as of 3

A global phylogeny of hCoV-19 sequences from GISAID (last accessed

ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R

MUSCLE: multiple sequence alignment with high accuracy and high throughput

Detecting individual sites subject to episodic diversifying selection

cluster: cluster analysis basics and extensions

umap: Uniform Manifold Approximation and Projection

Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis

clValid: An R Package for Cluster Validation

We thank ELIXIR Italy for providing the computing and bioinformatics facilities and Barbara De Marzo for technical assistance. We gratefully acknowledge the authors, originating and submitting laboratories of the sequences from GISAID's EpiFlu Database on which this research is based. This work was supported by the Italian Ministero dell'Università e Ricerca: PRIN 2017, Consiglio Nazionale delle Ricerche, H2020 projects EOSC-Life (GA 824087), EOSC-Pillar (GA 857650) and ELIXIR Converge (GA 871075), and Elixir-IIB.